ENDRA Life Sciences (NDRA) Accumulated Expenses (2016 - 2021)
ENDRA Life Sciences (NDRA) has disclosed Accumulated Expenses for 6 consecutive years, with $196079.0 as the latest value for Q3 2021.
- Quarterly Accumulated Expenses changed N/A to $196079.0 in Q3 2021 from the year-ago period, while the trailing twelve-month figure was $196079.0 through Sep 2021, changed N/A year-over-year, with the annual reading at $48260.0 for FY2020, 49.13% down from the prior year.
- Accumulated Expenses for Q3 2021 was $196079.0 at ENDRA Life Sciences, down from $211702.0 in the prior quarter.
- The five-year high for Accumulated Expenses was $211702.0 in Q1 2021, with the low at $29302.0 in Q4 2018.
- Average Accumulated Expenses over 5 years is $100627.7, with a median of $67452.0 recorded in 2017.
- The sharpest move saw Accumulated Expenses soared 223.74% in 2019, then plummeted 49.13% in 2020.
- Over 5 years, Accumulated Expenses stood at $40578.0 in 2017, then fell by 27.79% to $29302.0 in 2018, then skyrocketed by 223.74% to $94862.0 in 2019, then crashed by 49.13% to $48260.0 in 2020, then soared by 306.3% to $196079.0 in 2021.
- According to Business Quant data, Accumulated Expenses over the past three periods came in at $196079.0, $211702.0, and $48260.0 for Q3 2021, Q1 2021, and Q4 2020 respectively.